SCHEMBL19786622

SCHEMBL19786622

c1ccc(-c2ccc3c(c2)c2c(c4cc(-c5ccc6ccccc6c5)c5ccccc5c4n2-c2ccccc2)c2c4ccccc4n(-c4ccccc4)c32)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ATM Q13315 1/20 0.34
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
MTOR P42345 1/20 0.32
ESR1 P03372 3/20 0.32
ESR2 Q92731 3/20 0.32
GSTP1 P09211 1/20 0.32
GPR84 Q9NQS5 1/20 0.31
KMT2A Q03164 2/20 0.31
IL1R1 P14778 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
TLR4 O00206 1/20 0.31
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18810640 0.86 KDM4E (0.45) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL18810682 0.86 L3MBTL1 (0.47) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL22155478 0.85 HSD17B1 (0.35) KDM4EHSD17B1HSD17B2PIK3CDPIK3CA
SCHEMBL23741396 0.85 KDM4E (0.38) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL18810662 0.85 KDM4E (0.40) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL21432023 0.84 HTR2B (0.39) KDM4EKMT2AMEN1ALDH1A1MAPT
SCHEMBL17451665 0.84 L3MBTL1 (0.47) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL20312115 0.84 HSD17B1 (0.35) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL18810613 0.83 L3MBTL1 (0.38) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL27453295 0.82 L3MBTL1 (0.42) L3MBTL1KDM4EATMHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-10-03 US disclosed
WO-2018012781-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF ORC3, OR51E2, ORAI2 L3MBTL1 1707/4885KDM4E 442/4885ATM 3467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.